Transjugular Leadless Pacemaker in a Preschool Child With Nickel-Titanium Allergy Authors: Yang Liu, Yao Lin, Hongmao Wang, Wei Li, Mingming Zhang, Yanjun Deng, Jing Zhang, Yanyan Liu, Linyi Li, He Jiang, Lin Shi Published: 2026 ABSTRACT AbstractBackgroundLeadless pacemakers (L-PMs) have limited clinical application in low-weight young pediatric patients. Conventional transvenous pacemakers carry infection/allergy risks, with no established L-PM implantation protocols for metal-allergic pediatric populations.Case SummaryA 4-year-old child with third-degree atrioventricular block had previously undergone 3 failed transvenous pacemaker implantations, each complicated by poor incisional healing and skin ulceration of the subcutaneous pockets. Patch testing confirmed metal allergy. A leadless single-chamber pacemaker (Micra VR, Medtronic) was successfully implanted via the right internal jugular vein.DiscussionPediatric metal allergy to pacemaker casings is rare, and conventional pacing is unfeasible in such cases. Literature on transjugular L-PM implantation in low-weight children with nickel-titanium allergy is scarce, with no standardized venous access or procedural approaches reported.Take-Home MessageTransjugular L-PM implantation is a viable alternative for low-weight pediatric patients with pacemaker metal allergy and failed conventional pacing, providing a critical technical pathway for this high-risk population.Key words: bradycardia, cardiac pacemaker, pediatric surgery Implantation of a permanent cardiac pacemaker remains the primary treatment for life-threatening third-degree atrioventricular (AV) block in pediatric patients.1 Implantation can be performed via either endocardial or epicardial approaches, depending on patient weight.2 However, there is a lack of large-scale data or guidelines for references specifically addressing leadless pacemaker (L-PM) implantation in children. L-PMs offer distinct advantages over conventional transvenous pacemaker systems, key among these being the avoidance of pocket infections, impaired healing due to skin rejection, and lead fracture.3 Therefore, L-PMs are recommended for patients with abnormal implantation pathways, recurrent pacemaker infections, or those for whom conventional pacemaker implantation is particularly difficult or prone to severe complications.2 Take-Home Message •Transjugular leadless pacemaker implantation is a viable alternative for low-weight pediatric patients with pacemaker metal allergy and failed conventional pacing, providing a critical technical pathway for this high-risk population. Transjugular leadless pacemaker implantation is a viable alternative for low-weight pediatric patients with pacemaker metal allergy and failed conventional pacing, providing a critical technical pathway for this high-risk population. We report the case of a 4-year-old girl (weight: 16.2 kg, height: 101 cm) with allergy to pacemaker housing metals and intolerance to conventional pacing pathways, who eventually underwent successful transjugular L-PM implantation. This provides valuable practical experience for young, low-weight children with restricted vascular access and intolerance to conventional pacemaker implantation. Methods This was an observational study. Clinical data were collected through the hospital medical record system. Because of ethical restrictions and patient confidentiality, the raw clinical data cannot be made publicly available, but are available from the corresponding author on reasonable request. This study had approval from the Ethics Committee of the Capital Center for Children's Health, Capital Medical University (No: SHERLLM2025071). The child's parent provided signed informed consent. This study was performed in line with the principles of the Declaration of Helsinki and its later amendments. Clinical Case Clinical data At the age of 3 months, the patient had undergone surgical repair of an atrial septal defect and ventricular septal defect, subsequently developing persistent third-degree AV block. A 24-hour Holter monitor showed an average heart rate of 49 beats/min, complete AV block, and junctional escape rhythm, meeting the indications for permanent cardiac pacemaker implantation. The patient had an unrepaired muscular ventricular septal defect with intracardiac shunting, which meets the indication for epicardial lead implantation.1 At age 3 years and 9 months, she underwent the first epicardial permanent pacemaker implantation (X3SR01, Medtronic; epicardial leads: Medtronic CapSure Epi 4965) with the pocket located in the left upper abdomen. On postoperative day 13, she developed erythema and swelling at the pocket incision site. Daily wound dressing changes and anti-infective therapy were administered without improvement, and ulceration occurred at the incision and pocket sites, without significant redness, heat, pain, or exudate. Three months after this first pacemaker implant, she underwent pocket debridement and removal of the original device, followed by a second epicardial pacemaker implantation (X3SR01, Medtronic; epicardial leads: Medtronic CapSure Epi 4965) with the pocket implanted in the left chest wall. Over 1 month later, the pocket incision site ulcerated again, with poor wound healing. After debridement, the epicardial pacemaker and leads were removed 3 months after the second implantation, with subsequent skin grafting for repair. After pacemaker removal, the patient recurrently experienced Adams-Stokes syndrome. One month after the second device removal, a temporary pacemaker was implanted, followed by transvenous implantation of a permanent subendocardial pacemaker (X3SR01, Medtronic; endocardial lead: SelectSecure MRI SureScan 3830) with the pocket buried in the right chest wall. Rivaroxaban was administered for anticoagulation to prevent thrombosis. Postoperatively, skin breakdown recurred at the pocket site. After debridement and suturing of the pocket with 2 weeks of anti-infective therapy, the ulceration at the pacemaker pocket incision failed to improve, gradually enlarging to approximately 2 × 3 cm (Figure 1). Two months after the third implantation, the patient underwent removal of the original endocardial pacemaker and leads, followed by debridement and suturing. A temporary pacemaker was implanted via the left femoral vein. Images of the Pocket and Incision Sites for the First, Second, and Third Epicardial Pacemaker Implantations (A) Image showing poor healing of the left upper abdominal pocket and pocket incision during the first epicardial pacemaker implantation. (B) Image of the left thoracic wall pocket and poor healing of the pocket incision during the second epicardial pacemaker implantation. (C) Image showing poor healing of the right-sided chest wall pocket and pocket incision site during the third endocardial pacemaker implantation. Fungal and bacterial cultures from the pacemaker surface, pocket, electrode tip, and skin ulcer tissue were all negative. Pathological examination of myocardial tissue from the electrode tip showed minimal striated muscle tissue with focal degeneration and necrosis. Patch test indicated allergies to nickel and titanium (nickel sulfate (++), titanium oxalate (+); data provided, Figure 2). Genomic testing: copy number variation: region:[hg19]del(22) (q11.21q11.21) chr22:g.19026325_1570986del. Heterozygous mutation. Results of Patch Test: Nickel Sulfate (++), Titanium Oxalate (+) Given the recurrent skin ulceration and poor healing at the incision and pocket sites after 3 pacemaker implantations, combined with skin patch test results, an allergy to the pacemaker metal casing was considered. Discontinuation of pacemaker therapy led to recurrent episodes of severe life-threatening arrhythmias (Figures 3A and 3B). Implantation of an L-PM became necessary. Electrocardiogram (A) Torsades de pointes ventricular tachycardia (R-on-T phenomenon). (B) Sinus arrest after ventricular tachycardia conversion. Preoperative assessment 1.Cardiac anatomical assessment: Echocardiography and cardiac contrast-enhanced computed tomography assessed the patient's right ventricular dimensions. Combined measurements indicated a tricuspid valve root-to-apex distance of 31 to 32 mm (Figure 4). The Micra VR leadless pacemaker (MC1VR01, Medtronic) measures 25.9 mm in length, 6.7 mm in outer diameter, and has a volume of 1 cm3, satisfying the patient's cardiac dimensions. Cardiac anatomical assessment: Echocardiography and cardiac contrast-enhanced computed tomography assessed the patient's right ventricular dimensions. Combined measurements indicated a tricuspid valve root-to-apex distance of 31 to 32 mm (Figure 4). The Micra VR leadless pacemaker (MC1VR01, Medtronic) measures 25.9 mm in length, 6.7 mm in outer diameter, and has a volume of 1 cm3, satisfying the patient's cardiac dimensions. 2.Venous access assessment: Ultrasound indicated an inferior vena cava (IVC) diameter of 8.5 mm. Lower extremity venography revealed the distal right femoral vein diameter of only 5.08 mm. Furthermore, collateral circulation had developed in the left femoral vein due to occlusion (Figure 5). Given the patient's low weight (16.2 kg) and small venous caliber, implantation of a L-PM via the IVC route was unfeasible and could potentially cause severe vascular complications. On the other hand, ultrasound indicated the right internal jugular vein (IJV) diameter was approximately 10.4 mm, meeting operational criteria. Venous access assessment: Ultrasound indicated an inferior vena cava (IVC) diameter of 8.5 mm. Lower extremity venography revealed the distal right femoral vein diameter of only 5.08 mm. Furthermore, collateral circulation had developed in the left femoral vein due to occlusion (Figure 5). Given the patient's low weight (16.2 kg) and small venous caliber, implantation of a L-PM via the IVC route was unfeasible and could potentially cause severe vascular complications. On the other hand, ultrasound indicated the right internal jugular vein (IJV) diameter was approximately 10.4 mm, meeting operational criteria. Cardiac Imaging Findings (A) Echocardiogram 4-chamber view showing a tricuspid valve septal leaflet root-to-apex distance of 30.9 mm. (B) Cardiac contrast-enhanced computed tomography showing the length from the apex to the root of the septal leaflet of the tricuspid valve as 32.2 mm. Lower Extremity Venography Results Surgical procedure The patient was positioned supine with her head toward the end of the bed, feet at the head of the bed, with digital subtraction angiography (DSA) images inverted. After tracheal intubation under general anesthesia, routine disinfection and draping of bilateral neck skin were performed. The right internal jugular vein was successfully punctured using the Seldinger technique, and a 5-F sheath was placed. Under the guidance of a contrast catheter, an 11-F sheath was inserted over a guidewire for predilation, followed by the placement of a stiff guidewire into the IVC. After exchanging for an 18-F sheath for further predilation, a 1-cm transverse incision was made at the puncture site. A 27-F sheath was then advanced over the stiff guidewire to the mid right atrium, continuously flushed with heparinized saline. The Micra VR was delivered to the right ventricle via the sheath using a delivery system. Angiography confirmed Micra positioning in the inferior septum (Figure 6) with good local apposition. The Micra VR was released after applying controlled tension (Figure 7), and traction testing indicated secure fixation. Testing parameters (VVI mode, pacing rate: 60 beats/min) showed a pacing threshold of 0.7 V/0.24 ms, impedance of 760 Ω, and ventricular sensing of 12 mV, which were satisfactory. The tether was removed, followed by the delivery system. Intraoperative multiangle fluoroscopy was employed to avoid valvular injury. Cardiac ultrasound revealed no cardiac perforation or tricuspid regurgitation. The 27-F sheath was withdrawn, and the incision was managed with a figure-of-eight suture and pressure dressing. No bleeding or occlusion was observed in the internal jugular vein. Preimplantation Fluoroscopic Images of the Patient Without the Micra Leadless Pacemaker (A) RAO 30° + LAO 45°. (B) RAO 30°. LAO = left anterior oblique; RAO = right anterior oblique. Fluoroscopic Images of the Patient After Micra Leadless Pacemaker Delivery (A) RAO 30°. (B) AP. (C) LAO 45°. AP = anteroposterior; LAO = left anterior oblique; RAO = right anterior oblique. 1-month follow-up Pacing parameters: VVIR mode, sensing 10.5 mV, threshold 0.63 V/0.24 ms, impedance 450 Ω. Postoperative electrocardiogram: Ventricular pacing, heart rate 60 beats/min. Neck incision healed well after suture removal. Cardiac function was normal; the patient experienced no episodes of Adams-Stokes syndrome. Discussion This patient had developed third-degree AV block after undergoing congenital heart surgery, meeting the indications for permanent cardiac pacemaker implantation. However, recurrent poor wound healing with localized skin ulceration occurred at the abdominal and chest wall subcutaneous pacemaker pockets. Repeated fungal and bacterial cultures from the pacemaker surface, pocket, and ulcerated skin tissue were negative, representing a highly uncommon clinical scenario. Genetic testing revealed a deletion at chromosome 22q11.21 in the patient, which may cause DiGeorge syndrome. Children with DiGeorge syndrome exhibit abnormalities in T-cell numbers and function due to cellular immunodeficiency, clinically manifesting as allergic conditions such as atopic dermatitis, asthma, and food allergies.4 This patient had a history of rashes in friction-prone areas and mildly reduced T-lymphocyte and helper T-cell counts, consistent with partial DiGeorge syndrome.5 Skin allergy testing also revealed sensitivity to nickel and titanium components. Titanium constitutes the primary material for pacemaker metal casings. Therefore, a metal casing allergy was strongly suspected. Nickel-titanium alloys are extensively used in medical applications. In recent years, reports of associated allergic complications have progressively increased.6, 7, 8 Among nickel-titanium alloy allergies, allergic contact dermatitis is the most prevalent manifestation. It is currently recognized that the predominant allergic response type to these alloys is a T-cell-mediated type IV (delayed-type) hypersensitivity reaction.9 This sequence of reactions induces chronic inflammation, which upon re-exposure to nickel-titanium alloy allergens triggers pronounced clinical hypersensitivity reactions.10,11 Allergic responses may extend to the implant periphery, causing aseptic inflammation and implant loosening.12 Symptoms typically resolve promptly after implant removal in most patients. This case report presents a pediatric patient with a rare dermal hypersensitivity reaction to the pacemaker casing, precluding the use of a conventional subcutaneous pocket for pacemaker placement. Traditional pacing systems were therefore not feasible. However, cessation of pacing resulted in recurrent episodes of severe, life-threatening arrhythmias and Adams-Stokes syndrome, necessitating the implantation of an L-PM. L-PMs offer distinct advantages, including direct intracardiac implantation without the need for a subcutaneous pocket or transvenous leads, thereby mitigating risks associated with pocket site infections and impaired wound healing due to cutaneous rejection reactions. The patient, a 4-year-old child weighing 16.2 kg with a height of 101 cm, represents a young, low-weight pediatric case. The small cardiac chamber dimensions and the narrow caliber of the IVC access route in such patients significantly elevate the procedural risks compared to adults, including vascular injury (tear, stenosis, or occlusion) and tricuspid regurgitation. A comprehensive preoperative assessment of venous access diameter, along with right ventricular transverse dimensions and volume, is therefore critical to evaluate the feasibility of leadless pacemaker system implantation. The dimensions of the Micra VR were compatible with the patient's cardiac anatomy. The potential for future implantation of another L-PM could be considered as the child grows. Although L-PMs are typically implanted via an IVC approach, the femoral veins in young children are often diminutive and prone to occlusion, which can lead to complications such as pelvic venous syndrome.13 Preprocedural imaging in this case revealed that the femoral vein diameter did not meet the minimum required vascular diameter for the Micra delivery system. In contrast, the IJV provided a lumen of sufficient caliber for access. Literature supports the use of the IJV approach for patients at high risk with femoral access. Implantation via the IJV offers a relatively shorter and more direct path. Proximity to the tricuspid annulus facilitates optimal device orientation toward the interventricular septum, enhanced procedural maneuverability, reliable postprocedural hemostasis, and easier wound care.14,15 Consistent with published reports, successful device deployment was readily achieved via the IJV approach in this pediatric case (as shown in deployment sequence). Furthermore, the procedure used DSA image inversion technology, allowing the operator to maintain a conventional standing position, which optimized maneuvering for pediatric intervention (Figure 8). Intraoperative Setup for Transjugular Leadless Pacemaker Implantation (DSA Image Inversion) CT = computed tomography; DSA = digital subtraction angiography. Conclusions This case demonstrates successful transjugular implantation of a leadless pacemaker in a preschool-aged child with a rare pacemaker metal casing allergy, for whom conventional subcutaneous pacing was not feasible. It establishes a viable technical pathway for leadless pacing in similar low-weight, young children with restricted access or intolerance to conventional systems. Ethics Statement This study received approval from the Ethics Committee of the Capital Center for Children's Health, Capital Medical University (No: SHERLLM2025071). The child's parent provided signed informed consent. This study was performed in line with the principles of the Declaration of Helsinki and its later amendments. Funding Support and Author Disclosures The current study was funded by the Beijing Hospitals Authority Clinical Medicine Development of special funding support (YGLX202532), the New Quality Fund of Capital Institute of Pediatrics (XZYB-2025-01), and the Research Start-up Fund for Introduced Talents of Capital Institute of Pediatrics (YJRC202401). The authors have reported that they have no relationships relevant to the contents of this paper to disclose. Visual SummaryTimeline of the Patient's Overall ProgressionTimeEventsAge 3 moPatient underwent surgical repair of atrial septal defect and ventricular septal defect; subsequently developed persistent third-degree atrioventricular block.Age 3 y 9 moPatient underwent first epicardial pacemaker implantation (left upper abdomen pocket); postoperative pocket developed erythema, swelling, and ulceration.3 mo after first implantFirst device removed; underwent second epicardial pacemaker implantation (left chest wall pocket).3 mo after second implantSecond device removed due to recurrent ulceration; skin grafting performed.1 mo after second device removalPatient underwent third transvenous endocardial pacemaker implantation (right chest wall pocket); pocket ulceration recurred postoperatively.2 mo after third implantThird device removed; temporary pacemaker implanted via left femoral vein.Procedure day (age 4 y 7 mo)Successfully underwent transjugular leadless pacemaker implantation via right internal jugular vein.Postoperative days 1-7Neck incision healed well; no bleeding, hematoma, or allergic reaction.30-day follow-upPacing parameters stable; no arrhythmia or allergic events; cardiac function normal. Timeline of the Patient's Overall Progression